8814
G. Bartoli et al. / Tetrahedron Letters 42 (2001) 8811–8815
11. Compound
(1R*,2S*)-3-(dimethylamino)-2-methyl-1-
(d, 1H, CH, JHH=3.3), 7.10–7.20 (m, 2H, Ph), 7.40–7.50
(m, 2H, Ph); 13C NMR (CDCl3, 75 MHz): l=15.0
(CH3), 34.8 (CH), 45.7 (CH3), 62.3 (CH2), 78.0 (CH),
120.5 (C), 128.7 (CH), 130.6 (CH), 141.1 (C).
phenyl-1-propanol (2f) was recognized by comparison
with literature data: Risch, N.; Esser, A. Liebigs Ann.
Chem. 1992, 233–37.
13. (a) Roush, W. R. J. Org. Chem. 1991, 56, 4151–4157; (b)
Bernardi, A.; Gennari, C.; Goodman, J. M.; Paterson, I.
Tetrahedron: Asymmetry 1995, 6, 2613–2636; (c) Gennari,
C.; Vieth, S.; Comotti, A.; Vulpetti, A.; Goodman, J. M.;
Paterson, I. Tetrahedron 1992, 48, 4439–4458; (d) Esteve,
C.; Ferrero, M.; Romea, P.; Urp`ı, F.; Vilarrasa, J. Tetra-
hedron Lett. 1999, 40, 5079–5082.
14. (a) Bartoli, G.; Bellucci, M. C.; Alessandrini, S.; Mala-
volta, M.; Marcantoni, E.; Sambri, L.; Dalpozzo, R. J.
Org. Chem. 1999, 64, 1986–1992; (b) Bartoli, G.; Bosco,
M.; Bellucci, M. C.; Dalpozzo, R.; Marcantoni, E.; Sam-
bri, L. Org. Lett. 2000, 2, 45–47.
15. (a) Ballini, R.; Bosica, G.; Marcantoni, E.; Vita, P.;
Bartoli, G. J. Org. Chem. 2000, 65, 5854–5857; (b) Bar-
toli, G.; Bosco, M.; Dalpozzo, R.; De Nino, A.; Proco-
pio, A.; Sambri, L.; Tagarelli, A. Eur. J. Org. Chem.
2001, 2971–2976.
16. Typical procedure: To a CH2Cl2 (10 ml) solution of
b-ketoamide 1 (1 mmol) TiCl4 (1.5 equiv., solution 1 M
in CH2Cl2) was added at −78°C. After 30 min, BH3–
Me2S (5 equiv., solution 10 M in Me2S) was added
dropwise. After 3 h at −78°C, the reaction was quenched
with aqueous HCl (1 M) and extracted with CH2Cl2. The
organic layer was dried over MgSO4, filtered and evapo-
rated under reduced pressure. The crude products were
purified by flash chromatography on aluminiumoxide
(Et2O/petroleum ether=8/2) to give pure hydroxyamides
5.
12. Spectroscopic data for unknown products follow:
1
(2S*,3S*)-1-(dimethylamino)-2-methyl-3-pentanol (2a): H
NMR (CDCl3, 300 MHz): l=0.80 (d, 3H, CH3, JHH
=
7.2), 1.00 (t, 3H, CH3, JHH=7.5), 1.30–1.50 (m, 2H,
CH2), 2.05–2.20 (m, 2H, CH and CH2), 2.30 (s, 6H,
2CH3), 2.65 (dd, 1H, CH, JHH=12.5, JHH=10.7), 3.1 (bs,
1H, OH), 3.51 (dt, 1H, CH, JHH=9.0, JHH=3.6); 13C
NMR (CDCl3, 75 MHz): l=11.0 (CH3), 14.0 (CH3), 25.0
(CH2), 34.4 (CH), 45.5 (CH3), 63.0 (CH2), 76.5 (CH);
(2S*,3S*)-1-(dimethylamino)-2,4-dimethyl-3-pentanol (2b):
1H NMR (CDCl3, 300 MHz): l=0.83 (d, 3H, CH3,
J
HH=6.7), 0.89 (d, 3H, CH3, JHH=6.9), 1.00 (d, 3H,
CH3, JHH=6.6), 1.60–1.75 (m, 1H, CH), 1.80–1.95 (m,
1H, CH), 2.26 (s, 6H, 2CH3), 2.29 (dd, 1H, CH, JHH
12.6, JHH=5.4), 2.49 (dd, 1H, CH, JHH=12.6, JHH=7.2),
=
3.0 (bs, 1H, OH), 3.31 (dd, 1H, CH, JHH=2.4, JHH
=
8.4); 13C NMR (CDCl3, 75 MHz): l=11.7 (CH3), 19.2
(CH3), 19.6 (CH3), 30.8 (CH), 33.0 (CH), 46.5 (CH3),
64.6 (CH2), 78.9 (CH); (2S*,3S*)-1-(dimethylamino)-2-
1
methyl-3-octanol (2c): H NMR (CDCl3, 300 MHz): l=
0.77 (d, 3H, CH3,
JHH=6.9), 0.88 (t, 3H, CH3,
JHH=6.8), 1.20–1.40 (m, 7H, 3CH2 and 1H, CH2), 1.50–
1.65 (m, 1H, CH2), 2.00–2.20 (m, 2H, CH and CH2), 2.24
(s, 6H, 2CH3), 2.56 (dd, 1H, CH, JHH=13.2, JHH=11.7),
3.50–3.60 (m, 1H, CH), 3.7 (bs, 1H, OH); 13C NMR
(CDCl3, 75 MHz): l=14.0 (CH3), 14.4 (CH3), 22.7
(CH2), 26.3 (CH2), 32.0 (CH2), 32.1 (CH2), 34.5 (CH),
45.8 (CH3), 63.3 (CH2), 75.7 (CH); (2S*,3R*)-1-(dimethyl-
17. Compounds (2R*,3S*)-3-hydroxy-N,N,2-trimethylpentan-
amide (5a), (2R*,3R*)-3-hydroxy-N,N,2,4,4-pentamethyl-
pentanamide (5d), (2R*,3S*)-3-cyclohexyl-3-hydroxy-N,N,
2-trimethylpropanamide (5e), (2R*,3R*)-3-hydroxy-N,N,2-
trimethyl-3-phenylpropanamide (5f) were recognized by
comparison with literature data (see Ref. 19a).
1
amino)-2,4,4-trimethyl-3-pentanol (2d): H NMR (CDCl3,
300 MHz): l=0.93 (s, 9H, 3CH3), 0.94 (d, 3H, CH3,
J
J
HH=7.0), 1.85–2.00 (m, 1H, CH), 2.18 (dd, 1H, CH2,
HH=12.4, JHH=5.5), 2.22 (s, 6H, 2CH3), 2.34 (dd, 1H,
CH2, JHH=12.4, JHH=7.4), 2.9 (bs, 1H, OH), 3.42 (d,
1H, CH, JHH=2.4); 13C NMR (CDCl3, 75 MHz): l=
13.0 (CH3), 27.0 (CH3), 32.2 (CH), 35.4 (C), 46.1 (CH3),
66.3 (CH2), 78.9 (CH); (1S*,2S*)-1-cyclohexyl-3-
(dimethylamino)-2-methyl-1-propanol (2e): 1H NMR
(CDCl3, 300 MHz): l=0.88 (d, 3H, CH3, JHH=7.0),
0.85–1.00 (m, 2H, CH2), 1.05–1.30 (m, 2H, CH2), 1.30–
1.45 (m, 1H, CH2), 1.50–1.80 (m, 5H, 2CH2 and 1H
CH2), 1.80–1.90 (m, 1H, CH), 2.00–2.10 (m, 1H, CH),
18. Spectroscopic data for unknown products follow:
(2R*,3S*) - 3 - hydroxy - N,N,2,4 - tetramethylpentanamide
1
(5b): H NMR (CDCl3, 300 MHz): l=0.84 (d, 3H, CH3,
JHH=6.8), 1.03 (d, 3H, CH3, JHH=6.6), 1.11 (d, 3H,
CH3, JHH=7.1), 1.65–1.80 (m, 1H, CH), 2.85 (dq, 1H,
CH, JHH=7.1, JHH=2.1), 2.95 (s, 3H, CH3), 3.05 (s, 3H,
CH3), 3.40 (dd, 1H, CH, JHH=9.0, JHH=2.1), 4.7 (bs,
1H, OH); 13C NMR (CDCl3, 75 MHz): l=9.3 (CH3),
18.6 (CH3), 19.2 (CH3), 30.0 (CH), 35.2 (CH3), 35.6
(CH), 37.1 (CH3), 76.6 (CH), 177.6 (C); (2R*,3S*)-3-
hydroxy-N,N,2-trimethyloctanamide (5c): 1H NMR
(CDCl3, 300 MHz): l=0.88 (t, 3H, CH3, JHH=6.8), 1.13
(d, 3H, CH3, JHH=7.1), 1.20–1.35 (m, 6H, 3CH2), 1.40–
2.23 (s, 6H, 2CH3), 2.24 (dd, 1H, CH2, JHH=12.6, JHH
=
5.4), 2.42 (dd, 1H, CH2, JHH=12.6, JHH=7.2), 3.36 (dd,
1H, CH, JHH=2.4, JHH=8.7), 4.0 (bs, 1H, OH); 13C
NMR (CDCl3, 75 MHz): l=11.5 (CH3), 25.9 (CH2), 26.1
(CH2), 26.4 (CH2), 29.1 (CH2), 29.8 (CH2), 32.4 (CH),
40.3 (CH), 46.3 (CH3), 64.5 (CH2), 77.2 (CH); (1R*,2S*)-
3-(dimethylamino)-2-methyl-1-(4-nitrophenyl)-1-propanol
1.60 (m, 2H, CH2), 2.62 (dq, 1H, CH, JHH=7.1, JHH
=
2.1), 2.94 (s, 3H, CH3), 3.04 (s, 3H, CH3), 3.80–3.90 (m,
1H, CH), 4.6 (bs, 1H, OH); 13C NMR (CDCl3, 75 MHz):
l=9.4 (CH3), 13.8 (CH3), 22.4 (CH2), 25.5 (CH2), 31.9
(CH2), 33.6 (CH2), 35.1 (CH3), 37.2 (CH3), 38.5 (CH),
71.0 (CH), 177.8 (C); (2R*,3R*)-3-hydroxy-N,N,2-
trimethyl-3-(4-nitrophenyl)-propanamide (5g): 1H NMR
(CDCl3, 300 MHz): l=0.98 (d, 3H, CH3, JHH=7.2), 2.86
(dq, 1H, CH, JHH=7.2, JHH=2.2), 3.00 (s, 3H, CH3),
3.06 (s, 3H, CH3), 5.18 (d, 1H, CH, JHH=2.2), 5.5 (bs,
1H, OH), 7.50–7.60 (m, 2H, Ph), 8.15–8.25 (m, 2H, Ph);
13C NMR (CDCl3, 75 MHz): l=9.2 (CH3), 35.5 (CH3),
37.4 (CH3), 40.9 (CH), 72.5 (CH), 123.4 (CH), 126.9
1
(2g): H NMR (CDCl3, 300 MHz): l=0.69 (d, 3H, CH3,
JHH=6.8), 2.10–2.20 (m, 1H, CH), 2.37 (s, 6H, 2CH3),
2.30–2.60 (m, 2H, CH and CH2), 4.7 (bs, 1H, OH), 4.97
(d, 1H, CH, JHH=3.3), 7.40–7.50 (m, 2H, Ph), 8.15–8.25
(m, 2H, Ph); 13C NMR (CDCl3, 75 MHz): l=14.5
(CH3), 35.0 (CH), 45.6 (CH3), 62.4 (CH2), 77.7 (CH),
122.8 (CH), 127.6 (CH), 146.9 (C), 150.1 (C); (1R*,2S*)-
1-(4-bromophenyl)-3-(dimethylamino)-2-methyl-1-propanol
1
(2h): H NMR (CDCl3, 300 MHz): l=0.67 (d, 3H, CH3,
JHH=6.8), 2.00–2.10 (m, 1H, CH), 2.33 (s, 6H, 2CH3),
2.35–2.50 (m, 2H, CH and CH2), 4.4 (bs, 1H, OH), 4.78